CN116064773B - 一组用于检测血铅诱导儿童智力降低的生物标志物及其应用 - Google Patents
一组用于检测血铅诱导儿童智力降低的生物标志物及其应用 Download PDFInfo
- Publication number
- CN116064773B CN116064773B CN202211231474.8A CN202211231474A CN116064773B CN 116064773 B CN116064773 B CN 116064773B CN 202211231474 A CN202211231474 A CN 202211231474A CN 116064773 B CN116064773 B CN 116064773B
- Authority
- CN
- China
- Prior art keywords
- seq
- biomarker
- children
- dna methylation
- lead
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000090 biomarker Substances 0.000 title claims abstract description 112
- 239000008280 blood Substances 0.000 title claims abstract description 28
- 210000004369 blood Anatomy 0.000 title claims abstract description 28
- 208000036626 Mental retardation Diseases 0.000 title claims abstract description 20
- 230000007067 DNA methylation Effects 0.000 claims abstract description 57
- 230000003340 mental effect Effects 0.000 claims description 26
- 230000014509 gene expression Effects 0.000 claims description 24
- 238000012360 testing method Methods 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 238000012165 high-throughput sequencing Methods 0.000 claims description 2
- 108020004999 messenger RNA Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 5
- 238000012502 risk assessment Methods 0.000 abstract description 4
- 239000012634 fragment Substances 0.000 description 16
- 230000011987 methylation Effects 0.000 description 15
- 238000007069 methylation reaction Methods 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 101150066838 12 gene Proteins 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 231100000945 benchmark dose level lower confidence bound Toxicity 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000003827 upregulation Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 101150029429 38 gene Proteins 0.000 description 2
- 102000016897 CCCTC-Binding Factor Human genes 0.000 description 2
- 108010014064 CCCTC-Binding Factor Proteins 0.000 description 2
- 102100029952 Double-strand-break repair protein rad21 homolog Human genes 0.000 description 2
- 101000584942 Homo sapiens Double-strand-break repair protein rad21 homolog Proteins 0.000 description 2
- 206010027439 Metal poisoning Diseases 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 231100000914 benchmark dose level upper confidence bound Toxicity 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 208000008127 lead poisoning Diseases 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005183 environmental health Effects 0.000 description 1
- 230000004049 epigenetic modification Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 230000036630 mental development Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 231100000628 reference dose Toxicity 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211231474.8A CN116064773B (zh) | 2022-10-09 | 2022-10-09 | 一组用于检测血铅诱导儿童智力降低的生物标志物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211231474.8A CN116064773B (zh) | 2022-10-09 | 2022-10-09 | 一组用于检测血铅诱导儿童智力降低的生物标志物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116064773A CN116064773A (zh) | 2023-05-05 |
CN116064773B true CN116064773B (zh) | 2023-12-08 |
Family
ID=86182681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211231474.8A Active CN116064773B (zh) | 2022-10-09 | 2022-10-09 | 一组用于检测血铅诱导儿童智力降低的生物标志物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116064773B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5518886A (en) * | 1993-08-03 | 1996-05-21 | Fox Chase Cancer Center | Blood lead diagnostic assay |
CN107043806A (zh) * | 2016-12-13 | 2017-08-15 | 江苏省疾病预防控制中心 | 铅暴露工人岗前入职筛选微小rna标志物及其应用 |
EP3802856A1 (en) * | 2018-05-31 | 2021-04-14 | The Regents Of The University Of California | Dna methylation biomarker of aging for human ex vivo and in vivo studies |
-
2022
- 2022-10-09 CN CN202211231474.8A patent/CN116064773B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5518886A (en) * | 1993-08-03 | 1996-05-21 | Fox Chase Cancer Center | Blood lead diagnostic assay |
CN107043806A (zh) * | 2016-12-13 | 2017-08-15 | 江苏省疾病预防控制中心 | 铅暴露工人岗前入职筛选微小rna标志物及其应用 |
EP3802856A1 (en) * | 2018-05-31 | 2021-04-14 | The Regents Of The University Of California | Dna methylation biomarker of aging for human ex vivo and in vivo studies |
Non-Patent Citations (4)
Title |
---|
DNA Methylation Biomarkers of IQ Reduction are Associated with Long-term Lead Exposure in School Aged Children in Southern China;Cong Wan et al;Environ. Sci. Technol.;第55卷(第1期);412-422 * |
孕期铅暴露对胎儿及婴幼儿的影响;苗红;程蔚蔚;;上海交通大学学报(医学版)(第05期) * |
职业性铅接触的生物标志物研究进展;梁婧;;职业与健康(第23期) * |
铅暴露工人相关基因甲基化与遗传损伤关系的研究;何杨;王凯;庞妍;张瑶瑶;郑晓梅;彭珊茁;;中国工业医学杂志(第04期) * |
Also Published As
Publication number | Publication date |
---|---|
CN116064773A (zh) | 2023-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nicot et al. | Housekeeping gene selection for real-time RT-PCR normalization in potato during biotic and abiotic stress | |
Perini et al. | New approach using the real-time PCR method for estimation of the toxic marine dinoflagellate Ostreopsis cf. ovata in marine environment | |
Xie et al. | Co-exposure to polycyclic aromatic hydrocarbons and metals, four common polymorphisms in microRNA genes, and their gene-environment interactions: influences on oxidative damage levels in Chinese coke oven workers | |
CN111187839A (zh) | m5C甲基化相关调节基因在肝癌预后预测中的应用 | |
Boström et al. | Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genes | |
Ueda et al. | Genome-wide analyses of changes in translation state caused by elevated temperature in Oryza sativa | |
CN109563544A (zh) | 用于膀胱癌的尿监测的诊断测定 | |
Gao et al. | The development dynamics of the maize root transcriptome responsive to heavy metal Pb pollution | |
Li et al. | Barcoding for diatoms in the Yangtze River from the morphological observation and 18S rDNA polymorphic analysis | |
Choi et al. | Benzo [a] pyrene is associated with dysregulated myelo-lymphoid hematopoiesis in asthmatic children | |
CN113637742A (zh) | 一种高度近视基因检测试剂盒、以及一种高度近视遗传风险评估系统和方法 | |
CN113637744B (zh) | 微生物标志物在判断急性胰腺炎病程进展中的应用 | |
Erickson et al. | Assessment of normalization strategies for quantitative RT-PCR using microdissected tissue samples | |
Ye et al. | CpG site-specific methylation as epi-biomarkers for the prediction of health risk in PAHs-exposed populations | |
CN104878120B (zh) | 一种检测cpt1b基因突变的引物及试剂盒 | |
Meng et al. | Occupational lead exposure on genome-wide DNA methylation and DNA damage | |
CN116064773B (zh) | 一组用于检测血铅诱导儿童智力降低的生物标志物及其应用 | |
CN105209642A (zh) | 基因组测序和表观遗传分析的方法 | |
JP2022048190A (ja) | ドライアイ疾患の予後のための遺伝子シグネチャー | |
CN103911380A (zh) | Epas1基因突变体及其应用 | |
Zhi et al. | Long non-coding RNA RP11-342L8. 2, derived from RNA sequencing and validated via RT-qPCR, is upregulated and correlates with disease severity in psoriasis patients | |
CN109295239A (zh) | 边鸡分子标记的筛选方法及其应用 | |
Rutledge et al. | Gene expression analysis of primordial shoot explants collected from mature white spruce (Picea glauca) trees that differ in their responsiveness to somatic embryogenesis induction | |
US20220098665A1 (en) | Methods for predicting acute severe colitis treatment response | |
CN106755392B (zh) | 藻类培养中腔轮虫的快速定量检测qPCR方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Huimin Inventor after: Wan Cong Inventor after: Zhang Gan Inventor after: Dong Guanghui Inventor after: Li Jun Inventor after: Yang Boyi Inventor before: Ma Huimin Inventor before: Wan Cong Inventor before: Zhang Gan Inventor before: Dong Guanghui Inventor before: Li Jun Inventor before: Yang Boyi |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |